Trevena, Inc.

Trevena, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Trevena, Inc. is not a good value stock. Trevena, Inc. is not very popular among insiders. Trevena, Inc. is a mediocre stock to choose.
Log in to see more information.
Trevena, Inc. is a biopharmaceutical company, which focuses on the development and commercialization...

News

StockNews.com Initiates Coverage on Trevena (NASDAQ:TRVN)
StockNews.com Initiates Coverage on Trevena (NASDAQ:TRVN)

Ticker Report StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a report issued on Thursday. The brokerage set a "sell" rating on the biopharmaceutical company's stock...\n more…

Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com
Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com

Zolmax StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN - Free Report) in a research note published on Wednesday morning. The brokerage issued a sell rating on the biopharmaceutical...\n more…

Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com
Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com

Ticker Report Equities research analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a research note issued on Wednesday. The firm set a "sell" rating on the...\n more…

Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com
Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com

Zolmax StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN - Free Report) in a research report released on Tuesday. The firm issued a sell rating on the biopharmaceutical company's...\n more…

Trevena (NASDAQ:TRVN) Coverage Initiated at StockNews.com
Trevena (NASDAQ:TRVN) Coverage Initiated at StockNews.com

Ticker Report Analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a research report issued on Tuesday. The firm set a "sell" rating on the biopharmaceutical company's...\n more…

Financial Comparison: Trevena (NASDAQ:TRVN) and KALA BIO (NASDAQ:KALA)
Financial Comparison: Trevena (NASDAQ:TRVN) and KALA BIO (NASDAQ:KALA)

Ticker Report Trevena (NASDAQ:TRVN - Get Free Report) and KALA BIO (NASDAQ:KALA - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based...\n more…